Yes, we're on the same page. The pre-retired shares volume seemed to be comprised of traders who expected an immediate reward in that the OTC market would adjust the pps accordingly. When it didn't happen, they sold, not bothering to look at what the company was doing. All the freebies are out of the way. No more sugar high.

Generex is playing with the big dogs now. It would be great if the next major move was uplisting to NASDAQ. If so, everything that follows will be seen in light of that progress. Uplisting from near BK to NASDAQ is no small accomplishment.

I do agree that our slice of the pie will increase, as long as the company delivers on its business plan. If and when demand exceeds supply, the float will be smaller and that compression should result in a higher pps. Current shareholders have their shares and won't have to chase. Failure to deliver the business plan will result in same old, same old.